Actuate Therapeutics Inc (ACTU)
NASDAQ: ACTU
· Real-Time Price · USD
9.14
-0.75 (-7.58%)
At close: May 06, 2025, 3:59 PM
Actuate Therapeutics Inc Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for ACTU stock have an median target of 20, with a low estimate of 20 and a high estimate of 20. The median target predicts an increase of 118.82% from the current stock price of 9.14.
Latest Analyst Insight Report
According to 1 stock analyst, the rating for Actuate Therapeutics Inc is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
Financial Forecast this Year
Revenue This Year
n/a
Revenue Next Year
0
from 0
Increased by -%
EPS This Year
-1.12
from -3.26
Increased by 65.6%
EPS Next Year
-1.38
from -1.12
Increased by -23.2%